73 related articles for article (PubMed ID: 2064322)
1. Defective mitogen-induced cellular cytotoxicity in myelodysplastic syndromes. Recovery after alpha-interferon administration.
Eliopoulos G; Constantopoulou M; Coulocheri S; Vaiopoulos G; Eliopoulos A; Yataganas X
Anticancer Res; 1991; 11(2):685-9. PubMed ID: 2064322
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant alpha-interferon administration on peripheral blood lymphocyte subpopulations and natural killer cell activity in patients with refractory anemia with excess of blasts.
Eliopoulos G; Coulocheri S; Vaiopoulos G; Alexandrakis M; Ganotakis E; Eliopoulos A; Yataganas X
Nouv Rev Fr Hematol (1978); 1991; 33(1):21-4. PubMed ID: 1945821
[TBL] [Abstract][Full Text] [Related]
3. Defective mitogen-induced cellular cytotoxicity in untreated patients with active rheumatoid arthritis.
Vaiopoulos G; Kyriakou D; Papadaki H; Kaklamanis P; Eliopoulos GD
Rheumatol Int; 1994; 14(3):103-7. PubMed ID: 7839069
[TBL] [Abstract][Full Text] [Related]
4. Patients with chronic LGL-proliferative disease express high mitogen-induced cellular cytotoxicity which may be partially mediated by soluble cytolytic molecules.
Eliopoulos GD; Vaiopoulos G; Eliopoulos AG; Kyriakou D; Katrinakis G; Alexandrakis M
Haematologia (Budap); 1993; 25(3):215-22. PubMed ID: 8119634
[TBL] [Abstract][Full Text] [Related]
5. Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.
Villamor N; Reverter JC; Montserrat E; Urbano-Ispízua A; Vives-Corrons JL; Rozman C
Leukemia; 1992 Jun; 6(6):547-52. PubMed ID: 1376376
[TBL] [Abstract][Full Text] [Related]
6. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of recombinant human interferon alpha in myelodysplastic syndromes.
Nand S; Ellis T; Messmore H; Fisher SG; Gaynor E; Fisher RI
Leukemia; 1992 Mar; 6(3):220-3. PubMed ID: 1564960
[TBL] [Abstract][Full Text] [Related]
8. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
Appasamy R; Bryant J; Hassanein T; Van Thiel DH; Whiteside TL
Clin Immunol Immunopathol; 1994 Dec; 73(3):350-7. PubMed ID: 7955564
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy.
Millar BC; Bell JB; Powles RL
Br J Cancer; 1996 Jan; 73(2):236-40. PubMed ID: 8546912
[TBL] [Abstract][Full Text] [Related]
10. Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.
Ernstoff MS; Gooding W; Nair S; Bahnson RR; Miketic LM; Banner B; Day R; Whiteside T; Titus-Ernstoff L; Kirkwood JM
Cancer Res; 1992 Feb; 52(4):851-6. PubMed ID: 1737346
[TBL] [Abstract][Full Text] [Related]
11. [Research on the activity and quantity of natural killer cells and T lymphocytes in myelodysplastic syndrome patients].
Tan LJ; Pang GY; Hong WD
Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):319-21. PubMed ID: 8269761
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of lymphocyte lectin-dependent cytotoxicity in myelodysplastic syndromes.
Fontana L; De Sanctis G; De Rossi G; Bottari V; Petti MC; Ensoli F; Pasqualetti D; Mandelli F
Acta Haematol; 1989; 82(1):1-6. PubMed ID: 2505468
[TBL] [Abstract][Full Text] [Related]
13. Impaired alpha-interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromes.
Okabe M; Minagawa T; Nakane A; Sakurada K; Miyazaki T
Scand J Haematol; 1986 Aug; 37(2):111-7. PubMed ID: 3489981
[TBL] [Abstract][Full Text] [Related]
14. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P
Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440
[TBL] [Abstract][Full Text] [Related]
16. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
18. Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells.
Galvani DW; Nethersell AB; Cawley JC
Leuk Res; 1988; 12(3):257-62. PubMed ID: 3163399
[TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant alpha-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome.
Yataganas X; Eliopoulos G; Koulocheri S; Viniou N; Plata E; Panagiotidis P; Vayopoulos G; Meletis J; Fessas P
Ann Hematol; 1991 Jun; 62(6):225-9. PubMed ID: 1830225
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell cytotoxicity and alpha-interferon in early rheumatoid arthritis.
Taylor HG; Nixon NB; Dawes PT
Scand J Rheumatol; 1993; 22(6):280-3. PubMed ID: 8266028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
